Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVT-101 on Gait and Balance in AD, DLB, or PDD
NCT02910102Phase 2Completed
- Sponsor
- Sio Gene Therapies
- Start
- Oct 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of intepirdine in Alzheimer's disease (AD), dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD), sponsored by Sio Gene Therapies. Started Oct 2016; status: completed.
02
Drugs
intepirdine
03
Conditions
Alzheimer's disease (AD)dementia with Lewy bodies (DLB)Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT02910102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910102.